Korean ginseng extract attenuates reserpine-induced orofacial dyskinesia and improves cognitive dysfunction in rats

Natural Product Research

Volumn 25, Issue 7, 2011, Pages 704-715

  Sanghavi, Chetankumar R ^a   Barhate, Shrikant A ^a   Mahajan, Manoj S ^a   Mohan, Mahalaxmi ^a   Kasture, Sanjay B ^a  

^a MGV's Pharmacy College   (India)

Author keywords

cognition; elevated plus maze; free radicals; Korean ginseng; reserpine

Indexed keywords

CATALASE; GINSENG EXTRACT; GLUTATHIONE; KOREAN GINSENG EXTRACT; MALONALDEHYDE; NOOTROPIC AGENT; RESERPINE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; LIPID PEROXIDATION; LOCOMOTION; MALE; MASTICATION; MAZE TEST; MEMORY DISORDER; MOTOR DYSFUNCTION; NONHUMAN; OROFACIAL DYSKINESIA; RAT; REARING; TONGUE;

ANIMALS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; BRAIN; CATALASE; COGNITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSKINESIA, DRUG-INDUCED; FREE RADICALS; GLUTATHIONE; LIPID PEROXIDATION; MALE; MAZE LEARNING; OXIDATIVE STRESS; PANAX; PLANT EXTRACTS; RATS; RATS, WISTAR; RESERPINE; SUPEROXIDE DISMUTASE;

ANIMALIA; PANAX GINSENG; RATTUS;

EID: 79953686508     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786410802583031     Document Type: Article

References (29)

1. Andreassen, O.E., & Jørgensen, H.A. (2000). Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Progress in Neurobiology, 61, 525-541.
2. Beers, R.F. Jr, & Sizer, I.W. (1952). A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. Journal of Biological Chemistry, 195, 133-140.
3. Behl, C., Lezoulach, F., Widmann, M., Rupprecht, R., & Holsboer, F. (1996). Oxidative stressresistant cells are protected against haloperidol toxicity. Brain Research, 717, 193-195. (Pubitemid 26153452)
4. Behl, C., Rupprecht, R., Skutella, T., & Holsboer, F. (1995). Haloperidol-induced cell death: mechanism and protection with vitamin E in vitro. NeuroReport, 7, 360-364.
5. Benzi, G., & Moretti, A. (1995). Age-and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Radical Biology & Medicine, 19, 77-101.
6. Casey, D.E. (1995). Tardive dyskinesia-pathophysiology. In F.E. Bloom & D.J. Kupfer (Eds.), Psychopharmacology: Thefourth generation ofprogress (pp. 1497-1502). New York: Raven Press.
7. Ellman, G.L. (1959). Tissue sulfhydryl groups. Archives ofBiochemistry andBiophysics, 82, 70-77.
8. Gardos, G., & Cole, J.O. (1995). The treatment of tardive dyskinesias. In F.E. Bloom & D.J. Kupfer (Eds.), Psychopharmacology: The fourth generation ofprogress (pp. 1503-1511). New York: Raven Press.
9. Grandi, A., Mujamdar, A.M., & Patwardhan, B. (1994). A comparative pharmacological investigation of ashwagandha and ginseng. JournalofEthnopharmacology, 44, 131-135.
10. Ikeda, H., Adachi, K., Hasegawa, M., Sato, M., Hirose, N., & Koshikawa, A.R. (1999). Effects of chronic haloperidol and clozapine on vacuous chewing and dopamine-mediated jaw movements in rats: evaluation of a revised animal model of tardive dyskinesia. Journal of Neural Transmission, 106, 1205-1216. (Pubitemid 30009216)
11. Itoh, J., Nabeshima, T., & Kameyama, T. (1994). Utility of an elevated plus maze for dissociation of amnestic and behavioural effects of drugs in mice. European Journal of Pharmacology, 199, 171-177.
12. Jung, N.P., & Jin, S.H. (1996). Studies on the physiological and biochemical effects of Korean ginseng. Korean Journal of Ginseng Science, 20, 431-471.
13. Keum, Y.S., Park, K.K., Lee, J.M., Chun, K.S., Park, J.H., Lee, S.K., et al. (2000). Antioxidant and antitumor promoting activities of methanolic extract of heat processed ginseng. Cancer Letters, 150, 41-48. (Pubitemid 30123046)
14. Kim, Y.S., Kim, S.R., Markelonis, G.J., & Oh, T.H. (1998). Ginsenosides Rb1 and Rg3 protect culturted rat cortical cells from glutamate induced neurodegeneration. Journal of Neuroscience Research, 4, 426-432. (Pubitemid 28363204)
15. Kimura, T., Saunders, P.A., Kim, H.S., Rheu, H.H., Oh, K.N.K.N., & Ho, I.K. (1994). Interaction of ginsenosides with ligand bindings of GABAA and GABAB receptors. General Pharmacology, 25, 193-199.
16. Kleeb, S.R., Rizzo, M.S., Dagli, M.L.Z., & Frussa-Filho, R. (1999). Haloperidol increases spreading and nitric oxide production in macrophages from tumor-bearing mice: a possible mechanism for its antitumoral effect. International Journal of Immunopharmacology, 21, 575-580. (Pubitemid 29364264)
17. Lohr, J.B., Kuczenski, R., Bracha, H.S., Moir, M., & Jeste, D.V. (1990). Increased indices offree radicals activity in cerebrospinal fluid of patients with tardive dyskinesia. Biological Psychiatry, 28, 535-539. (Pubitemid 20298448)
18. Misra, H.P., & Fridovich, I. (1972). Generation of superoxide radicals during antioxidation of haemoglobin. Journal of Biological Chemistry, 247, 6960-6962.
19. Naidu, P.S., Singh, A., & Kulkarni, S.K. (2002). Carvedilol attenuates neuroleptic induced orofacial dyskinesia: possible antioxidant mechanism. British Journal of Pharmacology, 136, 193-200. (Pubitemid 34587665)
20. Neisewander, J.L., Castaneda, E., & Davis, D.A. (1994). Dose dependent differences in the development of reserpine induced oral dyskinesia in rats: support for a model of tardive dyskinesia. Psychopharmacology, 116, 79-84. (Pubitemid 24279600)
21. Neisewander, J.L., Lucki, I., & McGonigle, P. (1991). Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats. Journal of Pharmacology and Experimental Therapeutics, 257, 850-860.
22. Niehaus, W.G., & Samuelsson, B. (1968). Formation of malondialdehyde from phospholipids arachidonates during microsomal lipid peroxidation. European Journal of Biochemistry, 6, 126-130.
23. Peixoto, M.F., Abilio, V.C., Silva, R.H., & Frussa-Filho, R. (2003). Effects ofvalproic acid on an animal model of tardive dyskinesia. Behavioural Brain Research, 142, 229-233. (Pubitemid 36681560)
24. Pourcher, E., Cohen, H., Cohen, D., Baruch, P., & Bouchard, R.H. (1993). Organic brain dysfunction and cognitive deficits in young schizophrenic patients with tardive dyskinesia. Brain and Cognition, 23, 81-87.
25. Reddy, D.S., & Kulkarni, S.K. (1998). Possible role ofnitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging and dizocilpine-induced learning impairment. Brain Research, 799, 215-299.
26. Saggu, H., Cooksey, J., & Dexter, D. (1989). A selective increase in particulate superoxide desnutase activity in Parkinsonian substantia nigra. Journal of Neurochemistry, 53, 692-697. (Pubitemid 19207359)
27. Silva, R.H., Abilio, V.C., & Torres-Leite, D. (2002). Concomitant development of oral dyskinesia and memory deficits in reserpine-treated male and female rats. Behavioural Brain Research, 132, 172-178.
28. Sussman, A.N., Traan-Nguyen, L.T.L., & Neisewander, J.L. (1997). Acute reserpine administration elicits long-term spontaneous oral dyskinesia. European JournalofPharmacology, 37, 157-162.
29. Van Kampen, J., Robertson, H., Hagg, T., & Drobitch, R. (2003). Neuroprotective actions of the ginseng extract G115 in two rodent models ofParkinson's disease. Experimental Neurology, 184, 521-529. (Pubitemid 37444059)